The Complete Pharmacovigilance Course: Become Professional

Trace the drug development process from discovery and preclinical testing through three clinical trial phases to FDA review and post-market safety monitoring.

Learn core pharmacovigilance terminologies and definitions, including adverse drug reactions, adverse events, side effects, compliance, and CSR reporting from pre-marketing to post-marketing.

Discover why standardized international pharmacovigilance regulations matter for cross-border medicines, enabling consistent data collection and reporting, faster safety issue identification, and global collaboration among key regulatory bodies.

discover the responsibilities of the marketing authorisation holder in pharmacovigilance, including establishing a robust system, appointing a qualified person, managing adverse event reporting, risk management, labeling, and regulatory compliance.

Explore the consequences of non-compliance in pharmacovigilance, including regulatory actions and recalls. Understand how fines, legal liability, reputational damage, and operational disruption threaten public health, profitability, and market opportunities.

Identify sources of adverse events, from spontaneous reporting systems to postmarketing surveillance, and classify events by frequency, severity, and predictability, including allergic reactions and organ damage.

Identify and report adverse events, distinguishing serious from non-serious and expected from unexpected, using forms or online platforms to safeguard drug safety and confidentiality.

Explore the challenge and rechallenge concepts in pharmacovigilance, as stopping and reintroducing a drug helps assess causality, monitor safety, and manage adverse events.

Learn how aggregate reports in pharmacovigilance synthesize data from case reports, trials, and post-marketing surveillance to reveal adverse event frequency, trends, and demographic risk factors for regulatory decisions.

Identify, assess, and manage risks across a drug’s life cycle with a proactive risk management plan (RMP), detailing safety profile, risk minimization, and clear communication to regulators, clinicians, and patients.

Discover how signal detection in pharmacovigilance protects patient safety by identifying adverse events from spontaneous reporting systems like Vigibase and FAERS, CSR reports, trials, and real-world data.